(Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (Q3)Aug 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 843.33%7.83M | 229.97%5.58M | 138.68%6.13M | 138.68%6.13M | 93.34%6.87M | -80.06%830.08K | -64.68%1.69M | -53.57%2.57M | -53.57%2.57M | -40.07%3.55M |
-Cash and cash equivalents | 843.33%7.83M | 229.97%5.58M | 138.68%6.13M | 138.68%6.13M | 93.34%6.87M | -80.06%830.08K | -64.68%1.69M | -53.57%2.57M | -53.57%2.57M | -40.07%3.55M |
-Accounts receivable | 59.30%33.11K | --17.71K | 383.05%16.53K | 383.05%16.53K | --52.67K | --20.79K | ---- | -93.84%3.42K | -93.84%3.42K | ---- |
Total current assets | 320.20%9.04M | 141.81%6.66M | 127.64%7.26M | 127.64%7.26M | 116.86%8.2M | -49.84%2.15M | -46.38%2.76M | -45.96%3.19M | -45.96%3.19M | -41.02%3.78M |
Non current assets | ||||||||||
-Accumulated depreciation | -146.91%-9.07K | -232.22%-7.72K | -376.03%-6.37K | -376.03%-6.37K | -837.50%-5.03K | ---3.68K | ---2.33K | ---1.34K | ---1.34K | ---536 |
-Goodwill | 47.58%44.76K | -69.81%43.85K | -54.02%43.85K | -54.02%43.85K | -93.67%30.33K | -93.67%30.33K | -69.67%145.25K | -80.01%95.37K | -80.01%95.37K | 0.37%478.94K |
-Other intangible assets | 31.80%4.93M | -1.06%3.7M | 84.40%6.9M | 84.40%6.9M | 82.89%6.84M | 2.26%3.74M | 10.00%3.74M | 13.29%3.74M | 13.29%3.74M | 13.29%3.74M |
Regulatory assets | 115.25%44.74K | -10.05%33.16K | -60.90%25K | -60.90%25K | 59.46%57.92K | 97.98%20.79K | -36.66%36.86K | 15.17%63.95K | 15.17%63.95K | -55.60%36.33K |
Total assets | --11.63K | -58.10%15.44K | -85.99%8.48K | -85.99%8.48K | -85.53%5.26K | ---- | -36.66%36.86K | --60.53K | --60.53K | --36.33K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
-accounts payable | -71.04%122.37K | -64.91%117.7K | 137.55%139.22K | 137.55%139.22K | -53.64%88.93K | 1,053.34%422.5K | 2,124.28%335.44K | 345.44%58.61K | 345.44%58.61K | 106.60%191.83K |
-Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --12.3K |
Current accrued expenses | 170.30%171.92K | 54.21%153.35K | 39.63%162.36K | 39.63%162.36K | 147.41%305.12K | -22.03%63.61K | 96.94%99.44K | -29.52%116.28K | -29.52%116.28K | 326.73%123.33K |
Current deferred liabilities | --0 | --0 | -91.45%1.98K | -91.45%1.98K | --352 | --2.23K | --324 | --23.18K | --23.18K | ---- |
Current liabilities | -39.74%294.29K | -37.72%271.04K | 53.26%303.56K | 53.26%303.56K | 25.15%394.41K | 313.11%488.34K | 563.70%435.21K | 11.18%198.07K | 11.18%198.07K | 158.86%315.15K |
Non current liabilities | ||||||||||
Non current accrued expenses | -16.38%27.57K | -15.73%28.92K | 24.17%30.27K | 24.17%30.27K | 25.57%31.62K | 28.20%32.97K | --34.32K | --24.38K | --24.38K | --25.18K |
Total non current liabilities | -39.74%294.29K | -37.72%271.04K | 53.26%303.56K | 53.26%303.56K | 20.45%394.41K | 313.11%488.34K | 563.70%435.21K | 11.18%198.07K | 11.18%198.07K | 168.95%327.45K |
Shareholders'equity | ||||||||||
Share capital | 28.47%26.98M | 17.29%24.63M | 17.29%24.63M | 17.29%24.63M | 16.99%24.54M | 0.30%21M | 0.30%21M | 2.69%21M | 2.69%21M | 3.11%20.98M |
-common stock | 28.47%26.98M | 17.29%24.63M | 17.29%24.63M | 17.29%24.63M | 16.99%24.54M | 0.30%21M | 0.30%21M | 2.69%21M | 2.69%21M | 3.11%20.98M |
Additional paid-in capital | 23.15%1.62M | 17.90%1.53M | -28.46%1.47M | -28.46%1.47M | -35.04%1.32M | -35.25%1.31M | -35.21%1.3M | 8.85%2.05M | 8.85%2.05M | 10.43%2.04M |
Gains losses not affecting retained earnings | -2,761.54%-8.93K | ---3.04K | ---2.78K | ---2.78K | ---874 | ---312 | ---- | --0 | --0 | ---- |
Total equity | 311.46%9.12M | 129.49%6.73M | 121.65%7.34M | 121.65%7.34M | 92.79%8.26M | -53.80%2.22M | -47.75%2.93M | -48.13%3.31M | -48.13%3.31M | -37.79%4.29M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data